Laparoscopic Right Hemicoloectomy for Right Colon Cancer With a Medial-to-lateral Approach Orientated by SMA or SMV

Overview

A randomized controlled clinical trial to compare the outcomes of SMA- and SMV- orientated laparoscopic right hemicoloectomy for right colon cancer with a medial-to-lateral approach

Full Title of Study: “A Randomized Controlled Clinical Trial to Investigate the Effect of SMA- or SMV- Orientated Laparoscopic Right Hemicoloectomy for Right Colon Cancer With a Medial-to-lateral Approach”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2018

Detailed Description

In 2008, Germany scholar W. Hohenberger proposed the idea of complete mesocolic excision (CME) and central vascular ligation (CVL) for the standardization of colonic cancer surgery. This concept has been widely recognized and accepted. This radical operation attempts to remove the mesocolon intactly by careful dissection along the embryologic tissue planes and transection of the supplying vessels at their origin. For right-sided colon cancer, this approach involves division of the vessels at their origin from the superior mesenteric artery (SMA) and superior mesenteric vein (SMV). In our opinion, full exposure of the SMA and SMV is necessary to make sure that the origin of the colonic arteries being truly exposed and tied centrally at their origin and a maximal harvest of the regional lymphnodes. For locally advanced colon cancer, SMA- orientated surgery may be more meaningful to recerve a radical lymphadenectomy and bring benefit for their survival. However, in the traditional practise, the lymph node dissection is orientated by SMV and SMA is not exposed, tissue around SMA is left behind. In this study, eligible patients with right colon cancer will be randomly allocated to receive either SMA- or SMV- orientated laparoscopic right hemicoloectomy. 100 patients will be enrolled in each group. In SMV- orientated surgery group, SMA is not exposed and the left boundary of resection is the left side of SMV. In SMA- orientated surgery group, the left boundary of resection is the left side of SMA and SMA is exposed.Artery sheath is not necessarily to be opened. Postoperative pathology will be analyzed with the number of lymph nodes retrieved. Postoperative recovery process and long term survival will be followed.

Interventions

  • Procedure: SMA-orientated right hemicoloectomy
    • Laparoscopic right hemicoloectomy for right colon cancer with a medial-to-lateral approach orientated by SMA. The left boundary of resection is the left side of SMA, and artery sheath is not necessarily being opened.
  • Procedure: SMV-orientated right hemicoloectomy
    • Laparoscopic right hemicoloectomy for right colon cancer with a medial-to-lateral approach orientated by SMV. The left boundary of resection is the left side of SMV, and SMA is not exposed.

Arms, Groups and Cohorts

  • Active Comparator: SMA-orientated right hemicoloectomy
    • SMA-orientated right hemicoloectomy
  • Experimental: SMV-orientated right hemicoloectomy
    • SMV-orientated right hemicoloectomy

Clinical Trial Outcome Measures

Primary Measures

  • number of lymph nodes retrieved
    • Time Frame: 1 day

Secondary Measures

  • disease-free survival
    • Time Frame: 3 years
  • overall survival
    • Time Frame: 3 years
  • recurrence-free survival
    • Time Frame: 3 years
  • early complication rate
    • Time Frame: 30 days
    • Early complication is defined as a complication that occurred between the finish of the surgery and postoperative day. Complications includes anastomotic leakage, anastomotic bleeding, chyle leakage, wound infection, pulmonary embolism, myocardial infarction et al.The Clavien-Dindo Classification of Surgical Complications will be applied to access the degree of severity of postoperative complications.
  • operative time
    • Time Frame: 1 day

Participating in This Clinical Trial

Inclusion Criteria

  • Patients suitable for curative surgery between 18 – 85 years old; – American Society of Anesthesiologists(ASA) grade I-III; – Preoperative pathological diagnosis of adenocarcinoma; – Tumor located at the right colon; – Informed consent; – No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease. Exclusion Criteria:

  • Pregnant patient; – History of psychiatric disease; – Use of systemic steroids; – Simultaneous multiple primary colorectal cancer; – Preoperative enhanced CT scan of chest, abdominal and pelvic cavity shows: 1. Tumor involves the surrounding organs and combined organ resection needed to be done; 2. distant metastasis; 3. unable to perform R0 resection; – History of any other malignant tumor in recent 5 years; – Patients need emergency operation: mechanic ileus, perforation. – Not suitable for laparoscopic surgery (i.e., extensive adhesion caused by abdominal surgery, not suitable for artificial pneumoperitoneum, etc). – Conversion from laparoscopic surgery to laparotomy;

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 85 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • The First Affiliated Hospital with Nanjing Medical University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Fumin Zhang, Professor, Principal Investigator, Ethics Committee of the First Affiliated Hospital, Nanjing Medical University, Jiangsu Province Hospital
  • Overall Contact(s)
    • Yueming Sun, PhD, 02568136026, jssym@vip.sina.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.